Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients-Reference-Cited by-同舟云学术

Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients

Published:2020-03-20 Issue:4 Volume:24 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Kishimoto Kenji¹^ORCID,Hasegawa Daiichiro¹,Irie Kei²³,Okada Akira⁴,Nakamura Sayaka¹,Tamura Akihiro¹^ORCID,Yamamoto Nobuyuki¹,Kozaki Aiko¹,Saito Atsuro¹,Ishida Toshiaki¹,Fukushima Shoji²,Kosaka Yoshiyuki¹

Affiliation:

1. Department of Hematology & Oncology Children's Cancer Center Kobe Children's Hospital Kobe Japan

2. Department of Clinical Pharmacy Faculty of Pharmaceutical Science Kobe Gakuin University Kobe Japan

3. Department of Pharmacy Kobe City Hospital Organization Kobe City Medical Center General Hospital Kobe Japan

4. Department of Regulatory Science Faculty of Pharmacy Musashino University Tokyo Japan

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13696

Reference39 articles.

1. Impact of Conditioning Regimen in Allogeneic Hematopoetic Stem Cell Transplantation for Children with Acute Myelogenous Leukemia beyond First Complete Remission: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study

2. Therapeutic Drug Monitoring of Busulfan in Transplantation

3. Highly Variable Pharmacokinetics of Once-Daily Intravenous Busulfan When Combined with Fludarabine in Pediatric Patients: Phase I Clinical Study for Determination of Optimal Once-Daily Busulfan Dose Using Pharmacokinetic Modeling

4. Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation

5. Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of prophylactic echinocandin on the development of neurological complications in patients receiving busulfan‐containing conditioning regimens for stem cell transplantation: A single‐center retrospective study;Pediatric Transplantation;2024-04-10

2. Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia;Frontiers in Pediatrics;2021-12-10

3. Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation;The Journal of Clinical Pharmacology;2021-11-25

4. Two‐point blood sampling is sufficient and necessary to estimate the area under the concentration‐time curve for intravenous busulfan in infants and young children;Pediatric Blood & Cancer;2021-04-21

5. Personalized pharmacotherapy in oncology: Application of pharmacokinetic-pharmacodynamic criteria;FARM HOSP;2021